Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.
Published citations
[1] Bian, Y., Shan, G., Bi, G., et al. (2025). Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 status. Nature Communications, *16*, 9923. doi: 10.1038/s41467-025-65441-4 (IF:15.7)
[2] Bi, G., Liang, J., Bian, Y., et al. (2025). Targeting ALDH16A1 mediated thioredoxin lysosomal degradation to enhance ferroptosis susceptibility in SMARCA4-deficient NSCLC. Nature Communications, *16*, 8181. doi: 10.1038/s41467-025-63687-6 (IF:15.7)
[3] Shan, G., Bian, Y., Ren, S., et al. (2025). Sarcosine sensitizes lung adenocarcinoma to chemotherapy by dual activation of ferroptosis via PDK4/PDHA1 signaling and NMDAR-mediated iron export. Experimental Hematology & Oncology, *14*, 60. doi: 10.1186/s40164-025-00657-0 (IF:13.5)
MycAway® Spray (Ready-to-use) 支原体喷...
40605ES
Ceturegel® Matrix LDEV-Free基质胶
40183ES
MycAway® Treatment(1000×)-Mycoplas...
40607ES
Ceturegel® Matrix GFR,Phenol Red-F...
40186ES
Ceturegel® Matrix High Concentrati...
40187ES
Lysozyme 溶菌酶
10402ES
MycAway® Plus-Color One-Step Myco...
40612ES
MolPure® Endo-free Plasmid Mini Ki...
19021ES